Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 2009Expert Opinion on Therapeutic Patents

Recent developments in CCR2 antagonists

View Full Paper
Ask AI
Bookmark
Share

Authors

MXMingde XiaWestlake UniversityZSZhihua SuiRenaissance Life Therapies

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Xia et al. (2009) studied this question.

synapsesocial.com/papers/6a733807d98d9ee37dc8f67chttps://doi.org/10.1517/13543770902755129
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Chemokine receptor CCR2 expression by systemic sclerosis fibroblasts: Evidence for autocrine regulation of myofibroblast differentiation2005 · 107 citations
  2. 2Discovery of Disubstituted Cyclohexanes as a New Class of CC Chemokine Receptor 2 Antagonists2008 · 46 citations